Connection

RAJKUMAR VENKATRAMANI to Response Evaluation Criteria in Solid Tumors

This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Response Evaluation Criteria in Solid Tumors.
  1. Lenvatinib with etoposide plus ifosfamide in patients with refractory or relapsed osteosarcoma (ITCC-050): a multicentre, open-label, multicohort, phase 1/2 study. Lancet Oncol. 2021 09; 22(9):1312-1321.
    View in: PubMed
    Score: 0.049
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.